Zosano Pharma Corp (ZSAN) - Financial Analysis Review

Summary

Zosano Pharma Corp (Zosano Pharma), formerly ZP Holdings, Inc, is a pharmaceutical company that focuses on the development of transdermal microneedle patch system to deliver drug formulations through the skin for the treatment of a variety of indications. The companys lead product candidate include M207, a drug which is used orally and nasally to treat acute migraine. Zosano Pharmas pipeline product includes B104, for osteoporosis; and D107 for severe hypoglycemia. It works in partnership with other contract manufacturing organizations for clinical and commercial development of its products in geographies outside the United States.

GlobalData's Zosano Pharma Corp (ZSAN) - Financial Analysis Review provides a comprehensive insight into the company's history, business structure and operations. The report contains information on the company's key employees, key competitors and major products and services, as well as detailed financial ratios for the last 5 years.

Zosano Pharma Corp Key Recent Developments:

Nov 09,2016: Zosano Pharma Reports Third Quarter 2016 Financial Results
Sep 08,2016: Zosano Appoints Georgia Erbez as Chief Business Officer
Aug 10,2016: Zosano Pharma Reports Second Quarter 2016 Financial Results
May 12,2016: Zosano Pharma Reports First Quarter 2016 Financial Results
May 09,2016: Zosano Announces Appointment of John P. Walker as Chairman of the Board


This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope
- Business description - A detailed description of the company's operations and business divisions.
- Company history - Progression of key events associated with the company.
- Major products and services - A list of major products, services and brands of the company.
- Key competitors - A list of key competitors to the company.
- Key employees - A list of the key executives of the company.
- Executive biographies - A brief summary of the executives' employment history.
- Key operational heads - A list of personnel heading key departments/functions.
- Important locations and subsidiaries - A list of key locations and subsidiaries of the company, including contact details.
- Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note: Some sections may be missing if data is unavailable for the company.

Reasons to Buy

- Gain key insights into the company for academic or business research purposes. Key elements such as detailed business description and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
- Identify potential customers and suppliers with this report's analysis of the company's business structure, operations, major products and services.
- Examine potential investment and acquisition targets with this report's detailed insight into the company's business, financial and operational performance. Financial ratios presented for major public companies in the report include; revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.